Jitendra Wadhane - 27 Sep 2023 Form 4 Insider Report for Pyxis Oncology, Inc. (PYXS)

Role
Chief Accounting Officer
Signature
/s/ Jitendra Wadhane
Issuer symbol
PYXS
Transactions as of
27 Sep 2023
Net transactions value
+$4,675
Form type
4
Filing time
27 Sep 2023, 18:37:45 UTC
Previous filing
25 Sep 2023
Next filing
17 Nov 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PYXS Common Stock Purchase $4,675 +2,500 +1.1% $1.87 226,937 27 Sep 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person purchased all 2,500 shares of common stock in the open market at a price of $1.87 per share.